Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-26-416950

Director sold 30,000 shares at $27.70 ($830,904)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
MILNE GEORGE M JR Director 2026-10-05 Sale 10b5-1 −30,000 $27.70 $830,904 782,881 D: show line 1 in the form
Open-market sales · 30,000 sh · avg $27.70 · $830,904
Loading xslF345X06/ownership.xml…